Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity

Autor: Termini, James M., Martinez-Navio, José M., Gao, Guangping, Fuchs, Sebastian P., Desrosiers, Ronald C.
Zdroj: In Molecular Therapy - Methods & Clinical Development 12 March 2021 20:204-217
Databáze: ScienceDirect